Duval M, Klein JP, He W, et al. Hematopoietic stem-cell transplantation for acute leukemia in relapse or primary induction failure. J Clin Oncol. 2010;28(23):3730-8.

Armand P, Kim HT, Cutler CS, et al. A prognostic score for patients with acute leukemia or myelodysplastic syndromes undergoing allogeneic stem cell transplantation. Biol Blood Marrow Transplant. 2008;14(1):28-35.

Sorror ML, Storer BE, Fathi AT, et al. Development and Validation of a Novel Acute Myeloid Leukemia-Composite Model to Estimate Risks of Mortality. JAMA Oncol. 2017;3(12):1675-1682. 

Todisco E, Ciceri F, Oldani E, et al. The CIBMTR score predicts survival of AML patients undergoing allogeneic transplantation with active disease after a myeloablative or reduced intensity conditioning: a retrospective analysis of the Gruppo Italiano Trapianto Di Midollo Osseo. Leukemia. 2013;27(10):2086-91.

Dr. Michel Duval

Duval/CIBMTR Score for Acute Myelogenous Leukemia (AML) Survival

disease

cytogenetics

blasts

karnofsky

<p><span id="docs-internal-guid-b31c1b3f-b490-1063-03ed-94f006599a06">Predicts overall survival in AML patients with relapsed/refractory disease undergoing myeloablative transplant.</span></p>

Duval/CIBMTR Score

Joseph Maakaron, MD

The Duval Score for Acute Myelogenous Leukemia (AML) Survival predicts the transplantation survival of AML for patients in complete remission. 

DIPSS

CLL-IPI

HCT-CI

EB Medicine is the premier provider of evidence-based clinical content and CME resources for emergency medicine practitioners.

Listen to the VACO co-creators break down how to use VACO\, what it does\, and what it doesn’t.

Calc Function